CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 80 enrolled
Drug / intervention
Magnesium Sulfate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01828385
NCT01828385Phase 4Completed
CompareCT.gov

Effect of Magnesium Sulfate on the Reversal of Neuromuscular Blockade With Sugammadex: a Prospective, Randomized Double-blind Trial

Universidade Federal do Rio de Janeiro·interventional·Posted Apr 10, 2013·Updated Jan 21, 2015

In Brief

A Phase 4 clinical trial evaluating Magnesium Sulfate and Saline for Neuromuscular Blockade. Completed, enrolled 80 participants across 1 site.

Detailed Summary

The aim of this study is to determine the recovery time of moderate neuromuscular blockade with sugammadex in adults pretreated with magnesium sulfate.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeuromuscular Blockade
CountriesBrazil
CollaboratorsHospital Federal de Bonsucesso

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 10, 2013
Enrollment StartOct 1, 2012
Primary CompletionFeb 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 13.2 years ago

Interventions

Magnesium Sulfatedrug

Magnesium sulfate + rocuronium + sugammadex

Salinedrug

Saline + rocuronium + sugammadex